Search Results 661-670 of 17833 for monoclonal antibody
Monoclonal antibody. Basiliximab (Simulect) is an immunosuppressant that may be given during the first few days after surgery to prevent rejection ...
Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...
The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic is studying connections between monoclonal B-cell lymphocytosis and blood and lymph node ...
Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or ...
Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...
So, Aducanumab is a monoclonal antibody that is designed to be infused into the bloodstream, get into the brain, and remove amyloid plaques from the brain ...
Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...
Other medicines that are similar B-cell-depleting monoclonal antibodies may increase over time. These medicines are usually used when other treatments don't ...
And the Food and Drug Administration has approved monoclonal antibody therapies Inmazeb and Ebanga to treat Ebola. Therapy. Supportive care may help you feel ...
... monoclonal antibody therapy called sotrovimab, as well as an oral antiviral drug called Paxlovid and an IV antiviral drug called remdesivir. These drugs are ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!